Weill Cornell’s Medicine scientist claim to have discovered a new treatment for osteoporosis, which targets the blood vessels inside of bone, a molecule that promotes the growth of those blood vessels and reverses the weakening of bones and helps fracture, heals.
mHealth Application developer company Blink Health, brought legal charges against MedImpact Healthcare system, claiming the company to be a peddler of opioids.
Determined to cap the profits of private hospitals in Delhi and the NCR region, Delhi health minister Satyendra Jain has announced an array of new rules. He clearly stated that hospitals will be mandated to sell essential medicines at MRP and can no longer charge a markup.
With a view to reducing waiting time for patients, a group of doctors in a Nigerian hospital has unveiled a mobile app. The app is expected to bring a paradigm change in healthcare delivery services in the country.
Global healthcare is being led by the US with China following close behind. Europe is simply being a spectator to the developments that are unfolding on a global level.
A startup company called Nanochon secure 1st place at the 3DHEALS conference this year after delivering its pitch to a group of investors including Asimov Ventures, GE Ventures, Digital Industrialist.
Recently, scientists from the Centre for Disease Control and Prevention (CDC) were encouraging people to soak their clothes in a chemical named permethrin. They discovered that only 25 percent of ticks were found alive even after 24 hours of exposure. But they were unaware of the fact regarding how long permethrin remained active in textiles.
A new form of the deadly disease named pneumoconiosis or black lung disease has become more prevalent especially among coal miners in the US, with mining experience of more than ten years.
The research study revealed that tumor growth could be reduced by targeting the expression of Beta3-integrin along with microtubule-targeting agents (MTAs) chemotherapy. Beta3-integrin was the better anti-angiogenic target since it was expressed in tumor blood vessels, unlike normal cells.
To diagnose any kind of gastrointestinal problems, an ingestible sensor equipped with a genetically engineered bacteria was developed by an MIT research team. This ‘bacteria-on-a-chip’ combined sensors with ultra-low-power electronics, which could convert the bacterial response into a wireless signal that can be read by a smartphone.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.